-
EP3538117
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3538117
| EP3538117 - METHODS FOR ALLEVIATING HISTAMINE-INDEPENDENT PRURITUS USING NEUROTOXINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.05.2023 Database last updated on 14.06.2024 | |
| Former | Examination is in progress Status updated on 26.03.2021 | ||
| Former | Request for examination was made Status updated on 16.08.2019 | ||
| Former | The international publication has been made Status updated on 18.05.2018 | ||
| Former | unknown Status updated on 12.12.2017 | Most recent event Tooltip | 05.05.2023 | Application deemed to be withdrawn | published on 07.06.2023 [2023/23] | Applicant(s) | For all designated states Allergan, Inc. 2525 Dupont Drive Irvine, California 92612 / US | [2019/38] | Inventor(s) | 01 /
HSIA, Edward 21 Ensueno West Irvine, CA 92620 / US | 02 /
GIL, Daniel 2541 Point Del Mar Corona Del Mar, CA 92625 / US | [2019/38] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2019/38] | Application number, filing date | 17808255.8 | 09.11.2017 | [2019/38] | WO2017US60869 | Priority number, date | US201662420377P | 10.11.2016 Original published format: US 201662420377 P | US201762510044P | 23.05.2017 Original published format: US 201762510044 P | [2019/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018089640 | Date: | 17.05.2018 | Language: | EN | [2018/20] | Type: | A1 Application with search report | No.: | EP3538117 | Date: | 18.09.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.05.2018 takes the place of the publication of the European patent application. | [2019/38] | Search report(s) | International search report - published on: | EP | 17.05.2018 | Classification | IPC: | A61K35/74, A61K39/08, A61P17/04, A61P17/06 | [2019/38] | CPC: |
A61K38/4893 (EP,US);
A61K35/74 (EP,US);
A61K45/06 (US);
A61K9/0014 (US);
A61K9/0019 (US);
A61P17/00 (EP,US);
A61P17/04 (EP,US);
A61P17/06 (EP,US);
A61P17/08 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/38] | Title | German: | VERFAHREN ZUR LINDERUNG VON HISTAMIN-UNABHÄNGIGEM JUCKREIZ UNTER VERWENDUNG VON NEUROTOXINEN | [2019/38] | English: | METHODS FOR ALLEVIATING HISTAMINE-INDEPENDENT PRURITUS USING NEUROTOXINS | [2019/38] | French: | MÉTHODES PERMETTANT D'ATTÉNUER UN PRURIT INDÉPENDANT DE L'HISTAMINE À L'AIDE DE NEUROTOXINES | [2019/38] | Entry into regional phase | 22.05.2019 | National basic fee paid | 22.05.2019 | Designation fee(s) paid | 22.05.2019 | Examination fee paid | Examination procedure | 22.05.2019 | Examination requested [2019/38] | 22.05.2019 | Date on which the examining division has become responsible | 07.01.2020 | Amendment by applicant (claims and/or description) | 25.03.2021 | Despatch of a communication from the examining division (Time limit: M06) | 01.10.2021 | Reply to a communication from the examining division | 06.09.2022 | Despatch of a communication from the examining division (Time limit: M04) | 17.01.2023 | Application deemed to be withdrawn, date of legal effect [2023/23] | 03.02.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/23] | Fees paid | Renewal fee | 27.11.2019 | Renewal fee patent year 03 | 27.11.2020 | Renewal fee patent year 04 | 08.11.2021 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.11.2022 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]CN101554389 ; | [I]US6429189 (BORODIC GARY E [US]) [I] 1-31 *cf. claims 1, 5,12,19 and 20*; | [I]US2004213814 (ACKERMAN ALAN H [US]) [I] 1-31*cf. abstract, in particular example 8 depicted in section [0124]*; | [I] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2009, no. 81, Database accession no. 2009-Q70169, XP002777241 & CN101554389 A 20091014 (YE J) [I] 1-31 * abstract * | [I] - PARISA G ET AL, "Effects of botulinum toxin type A on histamine-induced itch and vasomotor responses in human skin", TOXICON, ELMSFORD, NY, US, vol. 51, doi:10.1016/J.TOXICON.2008.04.126, ISSN 0041-0101, (20080601), page 42, (20080529), XP022695814 [I] 1-31 *cf. page 42, Art. No. 124 at left-sided col.* DOI: http://dx.doi.org/10.1016/j.toxicon.2008.04.126 | [I] - SALARDINI ARASH ET AL, "Relief of intractable pruritus after administration of botulinum toxin A (botox): a case report.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200809), Database accession no. NLM18836352, XP009502687 [I] 1-31 * abstract * DOI: http://dx.doi.org/10.1097/WNF.0b013e3181672225 | [ ] - SALARDINI ARASH ET AL, "Relief of intractable pruritus after administration of botulinum toxin A (botox): a case report.", CLINICAL NEUROPHARMACOLOGY, (200809), vol. 31, no. 5, ISSN 1537-162X, pages 303 - 306 | [X] - HECKMANN MARC ET AL, "Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200204), Database accession no. NLM11907521, XP009502686 [X] 1-31 * abstract * DOI: http://dx.doi.org/10.1067/mjd.2002.120455 | [ ] - HECKMANN MARC ET AL, "Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study.", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY APR 2002, (200204), vol. 46, no. 4, ISSN 0190-9622, pages 617 - 619 | by applicant | US6306423 | US6312708 | US6585993 |